Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates
- 1 January 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 132 (1), 150-157
- https://doi.org/10.1016/0008-8749(91)90014-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cytokine modulation of mycobacterium tuberculosis growth in human macrophagesInternational Journal of Immunopharmacology, 1990
- Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.The Journal of Experimental Medicine, 1989
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediateBiochemistry, 1988
- Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.Journal of Clinical Investigation, 1988
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.The Journal of Experimental Medicine, 1983
- Virulence of Mycobacterium tuberculosis and Susceptibility to Peroxidative Killing SystemsJournal of General Microbiology, 1978
- Virulence and Resistance to Superoxide, Low pH and Hydrogen Peroxide among Strains of Mycobacterium tuberculosisJournal of General Microbiology, 1978
- Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival.The Journal of Experimental Medicine, 1975
- RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMESThe Journal of Experimental Medicine, 1971